Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Front Immunol. 2022 Jul 6;13:926714. doi: 10.3389/fimmu.2022.926714. eCollection 2022.
Exhausted CD8 T (Tex) cells are a distinct cell population that arise during persistent antigen exposure in the context of chronic infections and cancers. Although characterized by progressive loss of effector functions, high and sustained inhibitory receptor expression and distinct transcriptional and epigenetic programs, Tex cells are heterogeneous. Among these, a self-renewing TCF-1 Tex population, having unique characteristics and the ability to respond to immune-checkpoint blockade, gives rise to TCF-1 terminally Tex cells. These TCF-1 cells have stem cell-like properties similar to memory T cell populations, but the signals that regulate the developmental pathways and relationships among exhausted cell populations are still unclear. Here, we review our current understanding of Tex cell biology, and discuss some less appreciated molecules and pathways affecting T cell exhaustion. We highlight two co-stimulatory receptors, CD226 and CD137, and their role in inducing or restraining T cell exhaustion, as well as signaling pathways that may be amenable to pharmacological inhibition with a focus on Phosphoinositide-3 Kinase and IL-2 partial agonists. Finally, we discuss novel methods that may increase TCF-1 populations and therefore improve immunotherapy responsiveness. Understanding features of and pathways to exhaustion has important implications for the success of immunotherapy, including checkpoint blockade and adoptive T-cell transfer therapies.
耗竭的 CD8 T(Tex)细胞是在慢性感染和癌症中持续抗原暴露的情况下出现的一种独特细胞群体。尽管其特征是效应功能逐渐丧失、高水平和持续的抑制性受体表达以及独特的转录和表观遗传程序,但 Tex 细胞是异质性的。在这些细胞中,具有独特特征和对免疫检查点阻断反应能力的自我更新的 TCF-1 Tex 群体产生 TCF-1 终末 Tex 细胞。这些 TCF-1 细胞具有类似于记忆 T 细胞群体的干细胞样特性,但调节耗竭细胞群体发育途径和关系的信号仍不清楚。在这里,我们回顾了我们对 Tex 细胞生物学的现有理解,并讨论了一些不太受关注的影响 T 细胞耗竭的分子和途径。我们强调了两个共刺激受体 CD226 和 CD137 及其在诱导或抑制 T 细胞耗竭中的作用,以及可能适合药物抑制的信号通路,重点是磷酸肌醇 3 激酶和 IL-2 部分激动剂。最后,我们讨论了可能增加 TCF-1 群体从而提高免疫疗法反应性的新方法。了解耗竭的特征和途径对免疫疗法的成功具有重要意义,包括检查点阻断和过继性 T 细胞转移疗法。